Literature DB >> 31221680

Restricting Red-Cell Transfusions in Cardiac Surgery: No Increase in AKI.

Iain C Macdougall1, Toby Richards2.   

Abstract

Keywords:  TRICS-IIITrial; acute kidney injury; cardiac surgery; red-cell transfusions

Mesh：

Year:  2019        PMID： 31221680      PMCID： PMC6622416          DOI： 10.1681/ASN.2019050509

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN： 1046-6673            Impact factor:   10.121


× No keyword cloud information.
  10 in total

1.  Safety of a Restrictive versus Liberal Approach to Red Blood Cell Transfusion on the Outcome of AKI in Patients Undergoing Cardiac Surgery: A Randomized Clinical Trial.

Authors:  Amit X Garg; Neal Badner; Sean M Bagshaw; Meaghan S Cuerden; Dean A Fergusson; Alexander J Gregory; Judith Hall; Gregory M T Hare; Boris Khanykin; Shay McGuinness; Chirag R Parikh; Pavel S Roshanov; Nadine Shehata; Jessica M Sontrop; Summer Syed; George I Tagarakis; Kevin E Thorpe; Subodh Verma; Ron Wald; Richard P Whitlock; C David Mazer
Journal:  J Am Soc Nephrol       Date:  2019-06-20       Impact factor: 10.121

2.  Risk associated with preoperative anemia in cardiac surgery: a multicenter cohort study.

Authors:  Keyvan Karkouti; Duminda N Wijeysundera; W Scott Beattie
Journal:  Circulation       Date:  2008-01-02       Impact factor: 29.690

3.  Acute kidney injury after cardiac surgery: focus on modifiable risk factors.

Authors:  Keyvan Karkouti; Duminda N Wijeysundera; Terrence M Yau; Jeannie L Callum; Davy C Cheng; Mark Crowther; Jean-Yves Dupuis; Stephen E Fremes; Blaine Kent; Claude Laflamme; Andre Lamy; Jean-Francois Legare; C David Mazer; Stuart A McCluskey; Fraser D Rubens; Corey Sawchuk; W Scott Beattie
Journal:  Circulation       Date:  2009-01-19       Impact factor: 29.690

4.  Six-month outcomes after restrictive or liberal transfusion for cardiac surgery (TRICS III trial).

Authors:  L J Estcourt; D J Roberts
Journal:  Transfus Med       Date:  2019-04       Impact factor: 2.019

5.  Restrictive versus Liberal Transfusion for Cardiac Surgery.

Authors:  C David Mazer; Richard P Whitlock; Nadine Shehata
Journal:  N Engl J Med       Date:  2018-12-27       Impact factor: 91.245

Review 6.  Transfusion and risk of acute kidney injury in cardiac surgery.

Authors:  K Karkouti
Journal:  Br J Anaesth       Date:  2012-12       Impact factor: 9.166

Review 7.  Increased mortality, morbidity, and cost associated with red blood cell transfusion after cardiac surgery.

Authors:  Barnaby C Reeves; Gavin J Murphy
Journal:  Curr Opin Cardiol       Date:  2008-11       Impact factor: 2.161

Review 8.  Acute kidney injury associated with cardiac surgery.

Authors:  Mitchell H Rosner; Mark D Okusa
Journal:  Clin J Am Soc Nephrol       Date:  2005-10-19       Impact factor: 8.237

9.  Systematic review and consensus definitions for the Standardised Endpoints in Perioperative Medicine (StEP) initiative: renal endpoints.

Authors:  D R McIlroy; R Bellomo; F T Billings; K Karkouti; J R Prowle; A D Shaw; P S Myles
Journal:  Br J Anaesth       Date:  2018-09-21       Impact factor: 9.166

10.  Restrictive versus Liberal Fluid Therapy for Major Abdominal Surgery.

Authors:  Paul S Myles; Rinaldo Bellomo; Tomas Corcoran; Andrew Forbes; Philip Peyton; David Story; Chris Christophi; Kate Leslie; Shay McGuinness; Rachael Parke; Jonathan Serpell; Matthew T V Chan; Thomas Painter; Stuart McCluskey; Gary Minto; Sophie Wallace
Journal:  N Engl J Med       Date:  2018-05-09       Impact factor: 91.245
  10 in total
  2 in total

Review 1.  Plants with Therapeutic Potential for Ischemic Acute Kidney Injury: A Systematic Review.

Authors:  Arif Ali; Tiago Lima Sampaio; Haroon Khan; Philippe Jeandet; Esra Küpeli Akkol; Humaira Bahadar; Alice Maria Costa Martins
Journal:  Evid Based Complement Alternat Med       Date:  2022-05-23       Impact factor: 2.650

2.  Acute kidney injury following cardiopulmonary bypass in Jamaica.

Authors:  Lori-Ann Fisher; Sunil Stephenson; Marshall Tulloch Reid; Simon G Anderson
Journal:  JTCVS Open       Date:  2022-05-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.